KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Research & Development: 2016-2024

Historic Research & Development for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to $344.0 million.

  • Elanco Animal Health's Research & Development rose 2.30% to $89.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $356.0 million, marking a year-over-year increase of 4.09%. This contributed to the annual value of $344.0 million for FY2024, which is 5.20% up from last year.
  • According to the latest figures from FY2024, Elanco Animal Health's Research & Development is $344.0 million, which was up 5.20% from $327.0 million recorded in FY2023.
  • Over the past 5 years, Elanco Animal Health's Research & Development peaked at $369.0 million during FY2021, and registered a low of $321.0 million during FY2022.
  • Moreover, its 3-year median value for Research & Development was $327.0 million (2023), whereas its average is $330.7 million.
  • Its Research & Development has fluctuated over the past 5 years, first grew by 21.85% in 2020, then dropped by 13.01% in 2022.
  • Yearly analysis of 5 years shows Elanco Animal Health's Research & Development stood at $329.0 million in 2020, then climbed by 12.16% to $369.0 million in 2021, then declined by 13.01% to $321.0 million in 2022, then rose by 1.87% to $327.0 million in 2023, then grew by 5.20% to $344.0 million in 2024.